Departement
Klinische Forschung
Achtung: Diese Seite kann nur von Administratoren besucht werden, da Sie nicht freigeschalten wurde.
Zurück
Publications Meyer-Gerspach Anne Christin

Special Issue “Effects of Sugars and Sugar Alternatives on Human Health and Disease”, Nutrients

Beglinger C; Meyer-Gerspach AC. . 2024.

Diet-induced loss of adipose hexokinase 2 correlates with hyperglycemia.

Shimobayashi M; Thomas A; Shetty S; Frei IC; Wölnerhanssen BK; Weissenberger D; Vandekeere A; Planque M; Dietz N; Ritz D; Meyer-Gerspach AC; Maier T; Hay N; Peterli R; Fendt SM; Rohner N; Hall MN. eLife. 2023.

Effect of Oral Erythritol on Reward Responses after Repeated Exposure

Flad E; Teysseire F; Budzinska A; Weltens N; Rehfeld JF; Beglinger C; Van Oudenhove L; Wölnerhanssen BK; Meyer-Gerspach AC. . 2023.

Effects of a chronic intake of the natural sweeteners erythritol and xylitol on abdominal fat mass and glucose tolerance in patients with obesity

Bordier V; Teysseire F; Drewe J; Madörin P; Bieri O; Beglinger C; Wölnerhanssen BK; Meyer-Gerspach AC. . 2023.

Effects of a chronic intake of the natural sweeteners erythritol and xylitol on vascular function, abdominal fat and glucose tolerance in patients with obesity

Bordier V; Teysseire F; Drewe J; Madörin P; Bieri O; Schmidt-Trucksäss A; Beglinger C; Wölnerhanssen BK; Meyer-Gerspach AC. . 2023.

Effects of oral erythritol on reward responses after repeated exposure

Flad E; Teysseire F; Budzinska A; Weltens N; Rehfeld JF; Beglinger C; Wölnerhanssen BK; Van Oudenhove L; Meyer-Gerspach AC. . 2023.

Efficacy and safety of acute administration of D-allulose and erythritol in healthy participants

Teysseire F; Bordier V; Budzinska A; Weltens N; Beglinger C; Van Oudenhove L,; Wölnerhanssen BK; Meyer-Gerspach AC. . 2023.

Erythritol and xylitol do not affect arterial stiffness, abdominal fat, glucose tolerance, uric acid, hepatic enzymes, and creatinine in patients with obesity: a randomized controlled trial

Bordier V; Teysseire F; Drewe J; Madörin P; Bieri O; Schmidt-Trucksäss A; Hanssen H; Beglinger C; Wölnerhanssen BK; Meyer-Gerspach AC. . 2023.

Impact of Flavor Preference Learning on Reward Responses to Oral Erythritol

Flad E; Teysseire F; Budzinska A; Weltens N; Beglinger C; Wölnerhanssen BK; Van Oudenhove L; Meyer-Gerspach AC. . 2023.

Metabolic Effects and Safety Aspects of Acute D-allulose and Erythritol Administration in Healthy Subjects

Teysseire F; Bordier V; Budzinska A; Weltens N; Beglinger C; Van Oudenhove L; Wölnerhanssen BK; Meyer-Gerspach AC. . 2023.

Metabolic Effects and Safety Aspects of Acute D-allulose and Erythritol Administration in Healthy Subjects.

Teysseire F; Bordier V; Budzinska A; Van Oudenhove L; Weltens N; Beglinger C; Wölnerhanssen BK; Meyer-Gerspach AC. . 2023.

No differences in neural responses to oral administration of the non-caloric sweetener erythritol versus sucrose and sucralose

Budzinska A; Teysseire F; Flad E; Dupont P; Meyer-Gerspach AC; Weltens N; Van Oudenhove L. . 2023.

Prospective clinical cohort study: low incidence of Barrett esophagus but high rate of reflux disease at 5-year follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass.

Wölnerhanssen BK; Meyer-Gerspach AC; Nussbaumer R; Sauter M; Thumshirn M; Bueter M; Vetter D; Gubler C; Morell B; Jell A; Vieth M; Beglinger C; Peterli R; Fox M. Surgery for Obesity and Related Diseases. 2023.

Special Issue "Effects of Non-nutritive Sweeteners on Energy Intake and Human Health", Nutrients, 2023.

Beglinger C; Meyer-Gerspach AC. . 2023.

The Reward Value of Oral Erythritol in Comparison to Sucrose and Sucralose

Flad E; Teysseire F; Budzinska A; Weltens N; Van Oudenhove L; Beglinger C; Wölnerhanssen BK; Meyer-Gerspach AC. . 2023.

The Reward Value of Oral Erythritol in Comparison to Sucrose and Sucralose

Flad E; Teysseire F; Budzinska A; Weltens N; Beglinger C; Wölnerhanssen BK; Van Oudenhove L; Meyer-Gerspach AC. . 2023.

Absorption and Metabolism of the Natural Sweeteners Erythritol and Xylitol in Humans: A Dose-Ranging Study.

Bordier V; Teysseire F; Senner F; Schlotterbeck G; Drewe J; Beglinger C; Wölnerhanssen BK; Meyer-Gerspach AC. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022.

Absorption and metabolization of the naturally occuring sweeteners erythritol and xylitol in humans: A dose-ranging study

Bordier V; Teysseire F; Senner F; Schlotterbeck G; Drewe J; Beglinger C; Wölnerhanssen BK; Meyer-Gerspach AC. . 2022.

Absorption and metabolization of the natural sweetener erythritol in humans: a dose-ranging study

Bordier V; Teysseire F; Senner F; Schlotterbeck G; Drewe J; Beglinger C; Wölnerhanssen BK; Meyer-Gerspach AC. . 2022.

Effect of oral erythritol on subsequent energy intake during an ad libitum test meal

Teysseire F; Flad E; Bordier V; Rehfeld JF; Van Oudenhove L; Le Roux C; Beglinger C; Wölnerhanssen B; Meyer-Gerspach AC. . 2022.

Effects of oral preloads on subsequent energy intake during an ad libitum test meal

Teysseire F; Flad E; Bordier V; Rehfeld JF; Van Oudenhove L; Beglinger C; Wölnerhanssen B; Meyer-Gerspach AC. . 2022.

Erythritol: a non caloric future substitute for sugar?

Budzińska A; Van Troys E; Dupont P; Teysseire F; Meyer‐Gerspach AC; Weltens N; Van Oudenhove L. . 2022.

Erythritol and xylitol differentially impact brain networks involved in appetite regulation in healthy volunteers.

Meyer-Gerspach AC; Wingrove JO; Beglinger C; Rehfeld JF; Le Roux CW; Peterli R; Dupont P; O'Daly O; Van Oudenhove L; Wölnerhanssen BK. Nutritional neuroscience. 2022.

Oral erythritol affects subsequent energy intake in healthy humans: a randomized, controlled, crossover trial

Teysseire F; Flad E; Bordier V; Rehfeld JF; Van Oudenhove L; Le Roux C; Beglinger C; Wölnerhanssen B; Meyer-Gerspach AC. . 2022.

Oral Erythritol Reduces Energy Intake during a Subsequent ad libitum Test Meal: A Randomized, Controlled, Crossover Trial in Healthy Humans.

Teysseire F; Flad E; Bordier V; Budzinska A; Weltens N; Rehfeld JF; Beglinger C; Van Oudenhove L; Wölnerhanssen BK; Meyer-Gerspach AC. Nutrients. 2022.

Oral erythritol reduces subsequent energy intake: a randomized, controlled, crossover study in lean participants / United European Gastroenterology Journal

Teysseire F; Flad E; Bordier V,^; Rehfeld JF; Beglinger C; Van Oudenhove L; Wölnerhanssen B; Meyer-Gerspach AC. . 2022.

The Role of D-allulose and Erythritol on the Activity of the Gut Sweet Taste Receptor and Gastrointestinal Satiation Hormone Release in Humans: A Randomized, Controlled Trial.

Teysseire F; Bordier V; Budzinska A; Weltens N; Rehfeld JF; Holst JJ; Hartmann B; Beglinger C; Van Oudenhove L; Wölnerhanssen BK; Meyer-Gerspach AC. Journal of Nutrition. 2022.

Effect of a Chronic Intake of the Natural Sweeteners Xylitol and Erythritol on Glucose Absorption in Humans with Obesity.

Bordier V; Teysseire F; Schlotterbeck G; Senner F; Beglinger C; Meyer-Gerspach AC; Wölnerhanssen BK. Nutrients. 2021.

Effect of D-allulose on satiation hormone response, glycemic control and gastric empty-ing: a randomized, controlled trial

Teysseire F; Bordier V; Van Oudenhove L; Wölnerhanssen B; Meyer-Gerspach AC. . 2021.

Effect of the Natural Sweetener Xylitol on Gut Hormone Secretion and Gastric Emptying in Humans: A Pilot Dose-Ranging Study.

Meyer-Gerspach AC; Drewe J; Verbeure W; Roux CWL; Dellatorre-Teixeira L; Rehfeld JF; Holst JJ; Hartmann B; Tack J; Peterli R; Beglinger C; Wölnerhanssen BK. Nutrients. 2021.

Gastric emptying of solutions containing the natural sweetener erythritol and effects on gut hormone secretion in humans: A pilot dose-ranging study.

Wölnerhanssen BK; Drewe J; Verbeure W; le Roux CW; Dellatorre-Teixeira L; Rehfeld JF; Holst JJ; Hartmann B; Tack J; Peterli R; Beglinger C; Meyer-Gerspach AC. Diabetes, Obesity and Metabolism. 2021.

Gastroesophageal reflux disease and de novo incidence of Barrett’s esophagus ≥ 5 years after laparoscopic sleeve gastrectomy or Roux-Y-Gastric Bypass

Wölnerhanssen B; Meyer-Gerspach AC; Peterli R; Nussbaumer R; Sauter M; Thumshirn M; Beuter M; Vetter D; Gubler C; Vieth M; Beglinger C; Fox M. . 2021.

Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy: 5-year outcomes of merged data from two randomized clinical trials (SLEEVEPASS and SM-BOSS).

Wölnerhanssen BK; Peterli R; Hurme S; Bueter M; Helmiö M; Juuti A; Meyer-Gerspach AC; Slawik M; Peromaa-Haavisto P; Nuutila P; Salminen P. British Journal of Surgery. 2021.

Long-Term Effects of Laparoscopic Sleeve Gastrectomy and Roux-en-Y Gastric Bypass on Body Composition and Bone Mass Density.

Bühler J; Rast S; Beglinger C; Peterli R; Peters T; Gebhart M; Meyer-Gerspach AC; Wölnerhanssen BK. Obesity Facts. 2021.

The role of the gut sweet taste receptor in regulating CCK and PYY release in response to D-allulose and erythritol in humans

Teysseire F; Bordier V; Budzinska A; Weltens N; Rehfeld JF; Holst JJ; Hartmann B; Beglinger C; Van Oudenhove L; Wölnerhanssen B; Meyer-Gerspach AC. . 2021.

The role of the gut sweet taste receptor in regulating gut hormone release in response to the low-caloric sweeteners D-allulose and erythritol in humans: a randomized, controlled trial / United European Gastroenterology Journal

Teysseire F; Bordier V; Budzinska A; Weltens N; Rehfeld JF; Beglinger C; Van Oudenhove L; Wölnerhanssen B; Meyer-Gerspach AC. . 2021.

Barrett oesophagus and reflux-oesophagitis five years after laparoscopic sleeve gastrectomy and Roux-Y-gastric-bypass

Wölnerhanssen B; Meyer-Gerspach AC; Nussbaumer R; Thumshirn M; Sauter M; Vetter D; Gubler C; Bueter M; Vieth M; Beglinger C; Fox M; Peterli R. . 2020.

Common Pathways in Depression and Obesity: The Role of Gut Microbiome and Diets

Inta D.; Wolnerhanssen B.K.; Meyer-Gerspach A.C.; Lang E.; Schweinfurth N.; Mallien A.S.; Vasilescu A.-N.; Schmidt A.; Rea K.; Westendorf A.M.; Tremblay M.-E.; Sartorius A.; Gass P.; Cryan J.F.; Borgwardt S.; Lang U.E.. Current Behavioral Neuroscience Reports. 2020.

Einflüsse der Ernährung auf den Speichel

Meyer-Gerspach AC; Wölnerhanssen B. . 2020.

First-Phase Insulin and Amylin after Bariatric Surgery: A Prospective Randomized Trial on Patients with Insulin Resistance or Diabetes after Gastric Bypass or Sleeve Gastrectomy.

Nussbaumer R; Meyer-Gerspach AC; Peterli R; Peters T; Beglinger C; Chiappetta S; Drewe J; Wölnerhanssen B. Obesity Facts. 2020.

Metabolic effects of the natural sweeteners xylitol and erythritol: A comprehensive review.

Wölnerhanssen BK; Meyer-Gerspach AC; Beglinger C; Islam MS. Critical reviews in food science and nutrition. 2020.

[Health effects of sugar consumption and possible alternatives].

Wölnerhanssen BK; Meyer-Gerspach AC. Therapeutische Umschau. 2019.

Effect of cocoa on the brain and gut in healthy subjects: a randomised controlled trial.

Fox M; Meyer-Gerspach AC; Wendebourg MJ; Gruber M; Heinrich H; Sauter M; Woelnerhanssen B; Koeberle D; Juengling F. The British journal of nutrition. 2019.

Letter Regarding Article, "metabolomic Pattern Predicts Incident Coronary Heart Disease"

Wolnerhanssen B.K.; Meyer-Gerspach A.C.. Arteriosclerosis, Thrombosis, and Vascular Biology. 2019.

Quantification of Liver, Subcutaneous, and Visceral Adipose Tissues by MRI Before and After Bariatric Surgery.

Meyer-Gerspach AC; Peterli R; Moor M; Madörin P; Schötzau A; Nabers D; Borgwardt S; Beglinger C; Bieri O; Wölnerhanssen BK. Obesity Surgery. 2019.

Acute Effects of Glucose and Fructose Administration on the Neural Correlates of Cognitive Functioning in Healthy Subjects: A Pilot Study.

Zanchi D; Meyer-Gerspach AC; Schmidt A; Suenderhauf C; Depoorter A; Drewe J; Beglinger C; Wölnerhanssen BK; Borgwardt S. Frontiers in Psychiatry. 2018.

Effects of caloric and noncaloric sweeteners on antroduodenal motility, gastrointestinal hormone secretion and appetite-related sensations in healthy subjects.

Meyer-Gerspach AC; Biesiekierski JR; Deloose E; Clevers E; Rotondo A; Rehfeld JF; Depoortere I; Van Oudenhove L; Tack J. American Journal of Clinical Nutrition. 2018.

Endogenous GLP-1 alters postprandial functional connectivity between homeostatic and reward-related brain regions involved in regulation of appetite in healthy lean males: A pilotstudy

Meyer-Gerspach AC; Ly HG; Borgwardt S; Dupont P; Beglinger C; Van Oudenhove L; Wölnerhanssen BK. . 2018.

Endogenous GLP-1 alters postprandial functional connectivity between homeostatic and reward-related brain regions involved in regulation of appetite in healthy lean males: A pilotstudy.

Meyer-Gerspach AC; Ly HG; Borgwardt S; Dupont P; Beglinger C; Van Oudenhove L; Wölnerhanssen BK. Diabetes, Obesity and Metabolism. 2018.

Insulin resistance causes inflammation in adipose tissue.

Shimobayashi M; Albert V; Woelnerhanssen B; Frei IC; Weissenberger D; Meyer-Gerspach AC; Clement N; Moes S; Colombi M; Meier JA; Swierczynska MM; Jenö P; Beglinger C; Peterli R; Hall MN. Journal of Clinical Investigation. 2018.

The adverse effects of sugar consumption - Why we need to reduce it Die negativen Auswirkungen des Zuckers - Warum wir den Konsum besser reduzieren sollten

Meyer-Gerspach A.C.; Wolnerhanssen B.K.. Lymphologie in Forschung und Praxis. 2018.

The motilin agonist erythromycin increases hunger by modulating homeostatic and hedonic brain circuits in healthy women: a randomized, placebo-controlled study.

Zhao D; Meyer-Gerspach AC; Deloose E; Iven J; Weltens N; Depoortere I; O'daly O; Tack J; Van Oudenhove L. Scientific Reports. 2018.

Characterizing the dynamic interaction among gastric emptying, glucose absorption, and glycemic control in nondiabetic obese adults.

Wilbaux M; Wölnerhanssen BK; Meyer-Gerspach AC; Beglinger C; Pfister M. American journal of physiology. Regulatory, integrative and comparative physiology. 2017.

Deregulation of transcription factors controlling intestinal epithelial cell differentiation; a predisposing factor for reduced enteroendocrine cell number in morbidly obese individuals.

Wölnerhanssen BK; Moran AW; Burdyga G; Meyer-Gerspach AC; Peterli R; Manz M; Thumshirn M; Daly K; Beglinger C; Shirazi-Beechey SP. Scientific Reports. 2017.

Brain mechanisms underlying the effect of motilin receptor agonist erythromycin on hunger feelings in healthy volunteers

Zhao, D.; Meyer-Gerspach, A. C.; Deloose, E.; Weltens, N.; Depoortere, I.; Tack, J.; Van Oudenhove, L.. Neurogastroenterology and Motility. 2016.

Caloric and non-caloric artificial sweeteners have dissociable effects on gi motility in healthy volunteers

Meyer-Gerspach, A. C.; Deloose, E.; Biesiekierski, J.; Van Oudenhove, L.; Targid, J. Tack. Neurogastroenterology and Motility. 2016.

Differential effects of L-tryptophan and L-leucine administration on brain resting state functional networks and plasma hormone levels.

Zanchi D; Meyer-Gerspach AC; Suenderhauf C; Janach K; le Roux CW; Haller S; Drewe J; Beglinger C; Wölnerhanssen BK; Borgwardt S. Scientific Reports. 2016.

Effect of L-Tryptophan and L-Leucine on Gut Hormone Secretion, Appetite Feelings and Gastric Emptying Rates in Lean and Non-Diabetic Obese Participants: A Randomized, Double-Blind, Parallel-Group Trial.

Meyer-Gerspach AC; Häfliger S; Meili J; Doody A; Rehfeld JF; Drewe J; Beglinger C; Wölnerhanssen B. PLoS ONE. 2016.

Functional roles of low calorie sweeteners on gut function.

Meyer-Gerspach AC; Wölnerhanssen B; Beglinger C. Physiology & behavior. 2016.

Gut hormone secretion, gastric emptying, and glycemic responses to erythritol and xylitol in lean and obese subjects.

Wölnerhanssen BK; Cajacob L; Keller N; Doody A; Rehfeld JF; Drewe J; Peterli R; Beglinger C; Meyer-Gerspach AC. American Journal of Physiology - Endocrinology and Metabolism. 2016.

Gut Taste Stimulants Alter Brain Activity in Areas Related to Working Memory: a Pilot Study.

Meyer-Gerspach AC; Suenderhauf C; Bereiter L; Zanchi D; Beglinger C; Borgwardt S; Wölnerhanssen BK. Neuro-Signals. 2016.

Incretin effects, gastric emptying and insulin responses to low oral glucose loads in patients after gastric bypass and lean and obese controls.

Wölnerhanssen BK; Meyer-Gerspach AC; Peters T; Beglinger C; Peterli R. Surgery for Obesity and Related Diseases. 2016.

Mechanisms Regulating Insulin Response to Intragastric Glucose in Lean and Non-Diabetic Obese Subjects: A Randomized, Double-Blind, Parallel-Group Trial.

Meyer-Gerspach AC; Cajacob L; Riva D; Herzog R; Drewe J; Beglinger C; Wölnerhanssen BK. PLoS ONE. 2016.

Reply to letter to the editor: the tolerance of erythritol and xylitol based on effective dose methodologies.

Wölnerhanssen BK; Meyer Gerspach AC; Beglinger C. American Journal of Physiology - Endocrinology and Metabolism. 2016.

Dissociable behavioral, physiological and neural effects of acute glucose and fructose ingestion: A pilot study

Wolnerhanssen B.K.; Meyer-Gerspach A.C.; Schmidt A.; Zimak N.; Peterli R.; Beglinger C.; Borgwardt S.. PLoS ONE. 2015.

Enteroendocrine cell population is reduced in obesity and restored after sleeve gastrectomy (LSG)

Woelnerhanssen, B.; Meyer-Gerspach, A. C.; Manz, M.; Thumshirn, M.; Peterli, R.; Beglinger, C.; Burdyga, G.; Daly, K.; Moran, A.; Shirazi-Beechey, S.. British Journal of Surgery. 2015.

Semi-Mechanistic Model to Characterize Effects of Gastric Emptying on Glucose Absorption in Obese and Non-Obese Adults

Wilbaux, Melanie; Woelnerhanssen, Bettina; Beglinger, Christoph; Meyer-Gerspach, Anne Christin; Van den Anker, Johannes N.; Pfister, Marc. Journal of Pharmacokinetics and Pharmacodynamics. 2015.

DAYTIME SLEEPINESS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IS LINKED TO INSULIN RESISTANCE, ELEVATED LIVER FUNCTION TESTS AND FIBROSIS

Bernsmeier, C.; Weisskopf, D. M.; Mosimann, J.; Campana, B.; Meyer-Gerspach, A. C.; Steinert, R. E.; Blaser, L.; Jeker, L.; Terracciano, L.; Beglinger, C.; Heim, M. H.; Cajochen, C.. Journal of Hepatology. 2014.

Effect of a test meal on meal responses of satiation hormones and their association to insulin resistance in obese adolescents.

Beglinger S; Meyer-Gerspach AC; Graf S; Zumsteg U; Drewe J; Beglinger C; Gutzwiller JP. Obesity (Silver Spring, Md.). 2014.

Effect of glucagon-like peptide-1 receptor antagonism on appetite and food intake in healthy men.

Steinert RE; Schirra J; Meyer-Gerspach AC; Kienle P; Fischer H; Schulte F; Goeke B; Beglinger C. American Journal of Clinical Nutrition. 2014.

Erratum: Green tea extract enhances parieto-frontal connectivity during working memory processing (Psychopharmacology DOI: 10.1007/s00213-014-3526-1)

Schmidt A.; Hammann F.; Wolnerhanssen B.; Meyer-Gerspach A.C.; Drewe J.; Beglinger C.; Borgwardt S.. Psychopharmacology. 2014.

Gastric and intestinal satiation in obese and normal weight healthy people.

Meyer-Gerspach AC; Wölnerhanssen B; Beglinger B; Nessenius F; Napitupulu M; Schulte FH; Steinert RE; Beglinger C. Physiology & behavior. 2014.

Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease.

Bernsmeier C; Meyer-Gerspach AC; Blaser LS; Jeker L; Steinert RE; Heim MH; Beglinger C. PLoS ONE. 2014.

Green tea extract enhances parieto-frontal connectivity during working memory processing

Schmidt A.; Hammann F.; Wolnerhanssen B.; Meyer-Gerspach A.C.; Drewe J.; Beglinger C.; Borgwardt S.. Psychopharmacology. 2014.

Gut sweet taste receptors and their role in metabolism.

Meyer-Gerspach AC; Wölnerhanssen B; Beglinger C. Frontiers of Hormone Research. 2014.

Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial.

Steinert RE; Peterli R; Keller S; Meyer-Gerspach AC; Drewe J; Peters T; Beglinger C. Obesity (Silver Spring, Md.). 2013.

Effects of chenodeoxycholic acid on the secretion of gut peptides and fibroblast growth factors in healthy humans.

Meyer-Gerspach AC; Steinert RE; Keller S; Malarski A; Schulte FH; Beglinger C. Journal of Clinical Endocrinology and Metabolism. 2013.

GLUCOSE-INDUCED GLUCAGON-LIKE PEPTIDE 1 SECRETION IS DEFICIENT IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE

Bernsmeier, C.; Meyer-Gerspach, A. C.; Blaser, L. S.; Jeker, L.; Steinert, R. E.; Heim, M. H.; Beglinger, C.. Journal of Hepatology. 2013.

The role of the stomach in the control of appetite and the secretion of satiation peptides.

Steinert RE; Meyer-Gerspach AC; Beglinger C. American Journal of Physiology - Endocrinology and Metabolism. 2012.

The functional involvement of gut-expressed sweet taste receptors in glucose-stimulated secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY)

Steinert, R. E.; Gerspach, A. C.; Gutmann, H.; Asarian, L.; Drewe, J.; Beglinger, C.. Clinical nutrition (Edinburgh, Scotland). 2011.

The role of the gut sweet taste receptor in regulating GLP-1, PYY, and CCK release in humans.

Gerspach AC; Steinert RE; Schönenberger L; Graber-Maier A; Beglinger C. American Journal of Physiology - Endocrinology and Metabolism. 2011.